๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Association of on-treatment serum hepatitis B surface antigen level with sustained virological response to nucleos(t)ide analog in patients with hepatitis B e-antigen positive chronic hepatitis B

โœ Scribed by Soon Sun Kim; Dami Lee; Myoung Hee Lee; Jae Youn Cheong; Sung Won Cho

Book ID
117966636
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
838 KB
Volume
43
Category
Article
ISSN
1386-6346

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Outcome of hepatitis B e antigenโ€“negativ
Outcome of hepatitis B e antigenโ€“negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine
โœ George V. Papatheodoridis; Evangelini Dimou; Konstantinos Dimakopoulos; Spilios ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 415 KB ๐Ÿ‘ 1 views

We determined the clinical outcome of hepatitis e antigen (HBeAg)-negative chronic hepatitis B patients treated with long-term nucleos(t)ide analog therapy starting with lamivudine. We evaluated 201 such patients treated for 3.8 ุŽ 1.4 years and 2 historical similar cohorts: 1 treated with interferon

Prediction of sustained response to pegi
Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigenโ€“positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline
โœ Milan J. Sonneveld; Vincent Rijckborst; Charles A. B. Boucher; Bettina E. Hansen ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 231 KB ๐Ÿ‘ 1 views

Serum hepatitis B surface antigen (HBsAg) levels may reflect the immunomodulatory efficacy of pegylated interferon (PEG-IFN). We investigated within a large randomized trial whether quantitative HBsAg levels predict response to PEG-IFN in patients with hepatitis B e antigen (HBeAg)-positive chronic